Search - tctmd.com

Displaying 1 - 20 of 243

Sort: Relevancy | Date

News Industry News

SMT’s Hydra TAVR Valve Demonstrates Sustained Safety, Durability, and Hemodynamic Performance at 5 Years

November 19, 2025

News Conference News TCT 2025

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

Todd Neale

November 03, 2025

News Industry News

SMT’s Supraflex Cruz Shows Consistent and Robust Clinical Outcomes Across Key Global Studies Presented at TCT 2025

October 29, 2025

Presentation TCT 2025

TCT 1271: Safety and Efficacy of Biodegradable Polymer-coated Sirolimus-eluting Stent in the Treatment of Octo- and Nonagenarian All Comer Patients with Coronary Artery Disease – Results from the Prospective Multicenter Cruz Senior Study

Presenter: Gregor Nelles

October 28, 2025

Presentation TCT 2025

TCT 889: A Multicenter Observational Study in France Assessing Sirolimus-Eluting Biodegradable Polymer Stent for CAD Patients Undergoing PCI in Routine Clinical Practice

Presenter: Adnan Kastrati

October 28, 2025

Presentation TCT 2025

TCT 528: Sirolimus-Coated Balloon with Phospholipid Nanocarriers or Biodegradable Polymer Microspheres for Treatment of Coronary Artery Disease

Presenter: Pier Pasquale Leone

October 28, 2025

Presentation TCT 2025

Five-Year Outcomes of Biodegradable-Polymer Versus Durable-Polymer Second-Generation Drug-Eluting Stents: A Collaborative Individual Patient Data Analysis of 40,214 Patients Enrolled in 22 Randomized Trials

Presenter: Daniele Giacoppo

October 25, 2025

News Industry News

Positive 3-Year Results from FIRE Trial Demonstrate Supraflex Cruz’s Safety and Efficacy in Elderly Heart Attack Patients

September 15, 2025

Presentation TCT 2024

TCT 507: Evaluating Vascular Response to Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients With Diabetes Mellitus Using Optical Coherence Tomography: The OCID Study

Presenter: Atul Abhyankar

October 30, 2024

Presentation TCT 2024

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

Presenter: Hongbo Yang

October 30, 2024

Presentation TCT 2024

TCT 432: Long-Term Outcomes of Ultrathin Struts Biodegradable Polymer Sirolimus-Eluting Stent for Percutaneous Coronary Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Bernardo Cortese

October 29, 2024

Presentation TCT 2024

TCT 430: Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating in the Treatment of Native Coronary Artery Lesions: Inspiron Real Life II and Latitude Trials

Presenter: Paulo Caramori

October 29, 2024

Presentation TCT 2024

TCT 424: Pathological Analysis of Fibrin Deposition Around Stent Struts Within 1 Month After Circumferentially Coated Durable Polymer Drug-Eluting Stents and Abluminally Coated Biodegradable Polymer Drug-Eluting Stents for ACS

Presenter: Kazuki Aihara

October 29, 2024

Presentation TCT 2024

TCT 423: Biodegradable-Polymer Coated Sirolimus-Eluting Stents in Diabetic Patients: Insights From the S-FLEX UK II Registry

Presenter: Aayush Singal

October 29, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Industry News

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

June 18, 2024

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

L.A. McKeown

October 31, 2023

News Conference News TCT 2023

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Caitlin E. Cox

October 27, 2023

Presentation TCT 2023

TCT 781: Clinical outcomes of patients treated using 1-month dual antiplatelet therapy after biodegradable-polymer DES implantation

Presenter: Masaru Ishida

October 26, 2023

Advertisement

SMT’s Hydra TAVR Valve Demonstrates Sustained Safety, Durability, and Hemodynamic Performance at 5 Years

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

SMT’s Supraflex Cruz Shows Consistent and Robust Clinical Outcomes Across Key Global Studies Presented at TCT 2025

TCT 1271: Safety and Efficacy of Biodegradable Polymer-coated Sirolimus-eluting Stent in the Treatment of Octo- and Nonagenarian All Comer Patients with Coronary Artery Disease – Results from the Prospective Multicenter Cruz Senior Study

TCT 889: A Multicenter Observational Study in France Assessing Sirolimus-Eluting Biodegradable Polymer Stent for CAD Patients Undergoing PCI in Routine Clinical Practice

TCT 528: Sirolimus-Coated Balloon with Phospholipid Nanocarriers or Biodegradable Polymer Microspheres for Treatment of Coronary Artery Disease

Five-Year Outcomes of Biodegradable-Polymer Versus Durable-Polymer Second-Generation Drug-Eluting Stents: A Collaborative Individual Patient Data Analysis of 40,214 Patients Enrolled in 22 Randomized Trials

Positive 3-Year Results from FIRE Trial Demonstrate Supraflex Cruz’s Safety and Efficacy in Elderly Heart Attack Patients

TCT 507: Evaluating Vascular Response to Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients With Diabetes Mellitus Using Optical Coherence Tomography: The OCID Study

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

TCT 432: Long-Term Outcomes of Ultrathin Struts Biodegradable Polymer Sirolimus-Eluting Stent for Percutaneous Coronary Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

TCT 430: Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating in the Treatment of Native Coronary Artery Lesions: Inspiron Real Life II and Latitude Trials

TCT 424: Pathological Analysis of Fibrin Deposition Around Stent Struts Within 1 Month After Circumferentially Coated Durable Polymer Drug-Eluting Stents and Abluminally Coated Biodegradable Polymer Drug-Eluting Stents for ACS

TCT 423: Biodegradable-Polymer Coated Sirolimus-Eluting Stents in Diabetic Patients: Insights From the S-FLEX UK II Registry

What’s Going to Be Big at TCT 2024?

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

TCT 781: Clinical outcomes of patients treated using 1-month dual antiplatelet therapy after biodegradable-polymer DES implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content